BDX News and Press, Becton Dickinson and Company From 02/24/23

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When faced with myriad market ambiguities, investors may be well served to target the best dividend growth stocks to buy. In many ways, this investment category represents the best of both worlds. Fundamentally, passive-...

BD to Present at Cowen 43rd Annual Healthcare Conference PR Newswire FRANKLIN LAKES, N.J. , Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Cowe...

Becton, Dickinson and Company ( NYSE: BDX ) said that the U.S. Food and Drug Administration (FDA) approved BD Onclarity HPV Assay to be used with the ThinPrep Pap Test. The BD Onclarity HPV Assay can now be used with both BD SurePath Liquid-based Pap Test and Hologic Th...

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test PR Newswire Expands Access to BD HPV Test that More Precisely Identifies Patients' Risk for Cervical Cancer ...

BD Named as One of America's Best Large Employers PR Newswire FRANKLIN LAKES, N.J. , Feb. 15, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the company has been named to America's ...

Becton, Dickinson, and Company ( NYSE: BDX ) announced Wednesday that the FDA issued Emergency Use Authorization (EUA) for a combination test that can detect COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) infections simultaneously. The test, designed for use in the company...

BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test PR Newswire Single Test on BD MAX™ Molecular Diagnostic System Identifies and Differentiates Multiple Respiratory Infectious Diseases FRANKLIN LAKES, N.J. , ...

Summary William von Mueffling's 13F portfolio value increased this quarter from $11.04B to $11.81B. Cantillon added CDW Corp and increased BlackRock, Interactive Brokers, Entegris, and Armstrong World Industries during the quarter. The portfolio continues to be very concentrated wit...

Summary DexCom is young, innovative, admired, and (consequently) highly valued. Embecta is old, lethargic, lacks coverage, and (consequently) lowly valued. Growth and value investors may find respective equities interesting. I use DXCM and EMBC as a lens to view developments in ...